Page last updated: 2024-09-03

ilomastat and Hearing Loss

ilomastat has been researched along with Hearing Loss in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, YB; Choi, CH; Jang, CH; Jo, SY; Kim, MY; Park, BY	1

Other Studies

1 other study(ies) available for ilomastat and Hearing Loss

Article	Year
Matrix metalloproteinase inhibitor attenuates cochlear lateral wall damage induced by intratympanic instillation of endotoxin. International journal of pediatric otorhinolaryngology, 2012, Volume: 76, Issue:4 Topics: Animals; Anti-Bacterial Agents; Cochlea; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Guinea Pigs; Hearing Loss; Hydroxamic Acids; Indoles; Instillation, Drug; Labyrinthitis; Lipopolysaccharides; Male; Matrix Metalloproteinase Inhibitors; Oxytetracycline	2012

Article

Year

Matrix metalloproteinase inhibitor attenuates cochlear lateral wall damage induced by intratympanic instillation of endotoxin.

International journal of pediatric otorhinolaryngology, 2012, Volume: 76, Issue:4

Topics: Animals; Anti-Bacterial Agents; Cochlea; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Guinea Pigs; Hearing Loss; Hydroxamic Acids; Indoles; Instillation, Drug; Labyrinthitis; Lipopolysaccharides; Male; Matrix Metalloproteinase Inhibitors; Oxytetracycline

2012